Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.

2.

Childhood cancer survivors face new health problems later in life, study shows

3.

Genomic Newborn Screening Could Identify Childhood Cancer Predisposition

4.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

5.

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot